MINGCHEN HEALTH Co

MINGCHEN HEALTH Co EBIT

The EBIT of MINGCHEN HEALTH Co (002919.SZ) as of Nov 15, 2026 is 21.96 M CNY. In the previous year, EBIT was 31.33 M CNY — a change of -29.91% (lower).

EBIT

21.96 MCNY

YoY

-29.91%

Last updated:

In 2025, MINGCHEN HEALTH Co's EBIT was 21.96 M CNY, a -29.91% increase from the 31.33 M CNY EBIT recorded in the previous year.

The MINGCHEN HEALTH Co EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2018
31.79 M CNY
Jan 1, 2019
26.96 M CNY
Jan 1, 2020
105.15 M CNY
Jan 1, 2021
126.75 M CNY
Jan 1, 2022
-5.46 M CNY
Jan 1, 2023
57.94 M CNY
Jan 1, 2024
31.33 M CNY
Jan 1, 2025
21.96 M CNY
The MINGCHEN HEALTH Co EBIT history
YEAREBITYoY
21.96 MCNY-29.91%
31.33 MCNY-45.92%
57.94 MCNY-1,161.43%
-5.46 MCNY-104.31%
126.75 MCNY+20.54%
105.15 MCNY+290.06%
26.96 MCNY-15.19%
31.79 MCNY-42.94%
55.71 MCNY+2.90%
54.14 MCNY+5.65%
51.24 MCNY+59.09%
32.21 MCNY+37.55%
23.42 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

MINGCHEN HEALTH Co Revenue

MINGCHEN HEALTH Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
546.28 M CNY
31.79 M CNY
29.66 M CNY
Jan 1, 2019
517.46 M CNY
26.96 M CNY
23.08 M CNY
Jan 1, 2020
680.57 M CNY
105.15 M CNY
102.24 M CNY
Jan 1, 2021
744.15 M CNY
126.75 M CNY
133.49 M CNY
Jan 1, 2022
945.40 M CNY
-5.46 M CNY
25.39 M CNY
Jan 1, 2023
1.64 B CNY
57.94 M CNY
70.36 M CNY
Jan 1, 2024
1.38 B CNY
31.33 M CNY
46.72 M CNY
Jan 1, 2025
1.51 B CNY
21.96 M CNY
28.31 M CNY

MINGCHEN HEALTH Co Margins

MINGCHEN HEALTH Co stock margins

The MINGCHEN HEALTH Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of MINGCHEN HEALTH Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for MINGCHEN HEALTH Co.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
36.64 %
5.82 %
5.43 %
Jan 1, 2019
36.29 %
5.21 %
4.46 %
Jan 1, 2020
40.05 %
15.45 %
15.02 %
Jan 1, 2021
49.17 %
17.03 %
17.94 %
Jan 1, 2022
51.59 %
-0.58 %
2.69 %
Jan 1, 2023
59.69 %
3.54 %
4.30 %
Jan 1, 2024
51.76 %
2.27 %
3.38 %
Jan 1, 2025
54.12 %
1.45 %
1.87 %

MINGCHEN HEALTH Co Stock analysis

What does MINGCHEN HEALTH Co do? Mingchen Health Co., Ltd. generates revenue through the research, development, production, and sale of personal health care products including shampoo, conditioner, shower gel, gel water, and skin care products. The company owns multiple brands such as Diahuaxiu, Beauty King, High-tech Health, Yicai, Green Effect, Likoujian, Xiaoqiqi, and Golden Lion, which are distributed primarily within the domestic market. Its main customer segments consist of consumers seeking personal care solutions, with products targeting various needs in hair, body, and skin care. The firm's domestic market focus ensures consistent sales through established retail and distribution channels. The company's product portfolio spans hair care items like shampoo and conditioner, body care products such as shower gel and gel water, and skin care solutions. Brands like Diahuaxiu and Golden Lion are positioned in the personal care segment, while High-tech Health and Green Effect emphasize innovative and eco-friendly formulations. Domestic consumers purchase these products through standard retail networks, driving the company's revenue streams. The firm's domestic market strategy supports steady growth without reliance on international expansion. Mingchen Health's revenue is derived from selling branded personal care products across its domestic market. The brands Diahuaxiu, Beauty King, and Golden Lion are key contributors to sales, with High-tech Health and Green Effect appealing to health-conscious and environmentally aware customers. Product categories include shampoo, conditioner, shower gel, gel water, and skin care, all distributed through domestic channels. The company's focus on domestic sales ensures predictable revenue from established consumer segments. MINGCHEN HEALTH Co is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing MINGCHEN HEALTH Co's EBIT

MINGCHEN HEALTH Co's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of MINGCHEN HEALTH Co's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

MINGCHEN HEALTH Co's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in MINGCHEN HEALTH Co’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about MINGCHEN HEALTH Co stock

EBIT of MINGCHEN HEALTH Co is 21.96 M CNY in 2025.

EBIT of MINGCHEN HEALTH Co changed from 31.33 M CNY to 21.96 M CNY, representing a -29.91% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT MINGCHEN HEALTH Co since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's MINGCHEN HEALTH Co historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — MINGCHEN HEALTH Co

All Key Metrics — MINGCHEN HEALTH Co